文献速递神经肿瘤

转录因子免疫组化提高无功能垂体神经内分泌肿瘤诊断准确性并减少免疫阴性误分类

Transcription Factor Immunohistochemistry Improves Diagnostic Accuracy and Reduces Immunonegative Misclassification in Nonfunctional Pituitary Neuroendocrine Tumors.
PubMed 文献 · World Neurosurg · 2026-10-05

单中心回顾性研究纳入2021至2024年手术切除的173例无功能垂体神经内分泌肿瘤,比较传统垂体前叶激素免疫组化与谱系特异性转录因子免疫组化。结果显示转录因子染色可识别肿瘤谱系,170例单转录因子阳性患者中41例(24%)对应激素染色阴性,传统方法会误分类为免疫阴性。

要点

  • 转录因子免疫组化可提高无功能垂体神经内分泌肿瘤谱系诊断准确性。
  • 仅用激素免疫组化会使约24%单转录因子阳性肿瘤误判为免疫阴性。
  • SF-1、PIT-1、T-PIT分别阳性117例(66%)、18例(10%)、35例(20%)。

核心结论

  • 使用谱系特异性转录因子免疫组化可显著提高无功能垂体神经内分泌肿瘤正确病理诊断的准确性。

研究设计与样本

  • 单中心回顾性研究,纳入2021至2024年手术切除且同时行垂体前叶激素和谱系特异性转录因子免疫组化的无功能垂体神经内分泌肿瘤患者,共173例。

主要发现

  • SF-1、PIT-1、T-PIT免疫反应阳性分别为117例(66%)、18例(10%)、35例(20%)。
  • 3例(2%)对所有转录因子均无阳性染色,归类为免疫阴性。
  • 117例SF-1肿瘤中32例(27%)LH/FSH染色阴性。
  • 18例PIT-1肿瘤中2例(11%)PRL/GH/TSH染色阴性。
  • 35例TPIT肿瘤中7例(20%)ACTH染色阴性。

临床怎么用

  • 对手术切除的无功能垂体神经内分泌肿瘤应加做谱系特异性转录因子免疫组化以正确分型。
  • 仅依赖垂体前叶激素免疫组化可能将部分转录因子阳性肿瘤误判为免疫阴性。

局限性

  • 单中心回顾性研究,样本来自单一机构2021至2024年手术病例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Anterior pituitary hormone immunohistochemistry (IHC) for surgically resected nonfunctional pituitary neuroendocrine tumors (NF PitNET) underreports true rates of tumor lineage and biases toward immunonegative tumors. Here we compare our use of traditional IHC methods for identification of anterior pituitary hormones versus identification of lineage specific transcription factors (TF) to correctly identify NF PitNET lineage and review the literature for studies evaluating its efficacy. METHODS: A single institution, retrospective study of NF PitNETs undergoing surgical resection between 2021 and 2024 at the University of [blinded for review] was performed. Patients were included for study if pathology specimens had IHC performed for anterior pituitary hormones and lineage specific TF. RESULTS: A total of 173 patients with NF PitNETs were included. When stained for the lineage specific TFs: SF-1, PIT-1, and T-PIT, immunoreactivity was observed in 117 (66%), 18 (10%), and 35 (20%) tumors, respectively. Three (2%) patients demonstrated no positive staining for any TF and were classified as immunonegative. Of the 117 SF-1 tumors, 32 (27%) showed no positive staining for LH/FSH. For the 18 PIT-1 tumors, two (11%) showed no positive staining for PRL/GH/TSH. For the 35 TPIT tumors, 7 (20%) showed no staining for ACTH. Overall, of the 170 patients who had positive staining for a single TF, 41 (24%) did not show IHC staining for their corresponding anterior pituitary hormones and thus would have been classified as immunonegative PitNETs. CONCLUSION: Use of IHC for identification of lineage specific TF markedly improves the accuracy of correct pathological diagnosis of NF PitNETs.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hanks T, Abecassis ZA, Eaton J, et al. Transcription Factor Immunohistochemistry Improves Diagnostic Accuracy and Reduces Immunonegative Misclassification in Nonfunctional Pituitary Neuroendocrine Tumors. World Neurosurg. 2026. PMID: 42833555. doi:10.1016/j.wneu.2026.125390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。